Mai Chao, Qiu Li, Zeng Yong, Tan Xingqin
Department of Emergency, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Department of Emergency, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Front Physiol. 2021 Sep 20;12:678838. doi: 10.3389/fphys.2021.678838. eCollection 2021.
Ellis is rich in geniposide, which can be transformed into the anti-oxidant and anti-inflammatory agent genipin. Genipin exhibits greater efficacy than geniposide, but it is unstable and difficult to preserve. In this study, a mouse model for sepsis was established by cecal ligation and puncture, and then we explored the effects and mechanism of strain Shirota (LcS) on the enhancement of the ability of geniposide to reduce sepsis and decrease inflammatory and oxidative levels in mice by the regulation of sirtuin type 1 (SIRT1). The mice were evaluated and analyzed by the open field test, Morris water maze test, flow cytometry, kit assay, qPCR, and western blot. The LcS + geniposide increased the survival rate in mice with sepsis, and increased the total travel distance, number of times the mice stood up, amount of time the mice spent grooming their fur, duration in the target quadrant, and crossing area number. The testing of mouse nerve cells showed that LcS + geniposide reduced the rate of nerve cell apoptosis caused by sepsis. LcS + geniposide also decreased the amount of inflammatory-related indicators of TNF-α, IL-6, and IL-1β, and the oxidation-related levels of malondialdehyde (MDA) in the hippocampi of septic mice, and it increased the oxidase activities of superoxide dismutase (SOD) and catalase (CAT). Additionally, LcS + geniposide increased the SOD1, SOD2, and CAT mRNA expression in the hippocampi of mice with sepsis and decreased the expression of TNF-α, IL-1β, NF-κB, and p53 mRNA. LcS+geniposide also increased the SIRT1 protein expression and decreased the Ac-FOXO1, Ac-NF-κB, and Ac-p53 protein expression in the hippocampi of mice with sepsis. We also observed that LcS + geniposide decreased the inflammatory and oxidative damage in the mice with sepsis. The effect of LcS + geniposide was similar to that of the drug dexamethasone and stronger than the effect of geniposide utilized alone. LcS also enhanced the ability of geniposide to activate SIRT1 and decrease the inflammation and oxidative stress in the septic mice, and it achieved an effect same with that obtained by the use of the drug dexamethasone.
栀子富含京尼平苷,其可转化为抗氧化和抗炎剂京尼平。京尼平的疗效优于京尼平苷,但它不稳定且难以保存。在本研究中,通过盲肠结扎和穿刺建立了脓毒症小鼠模型,然后我们探讨了罗伊氏乳杆菌(LcS)通过调节1型沉默调节蛋白(SIRT1)增强京尼平苷降低小鼠脓毒症能力以及降低炎症和氧化水平的作用及机制。通过旷场试验、莫里斯水迷宫试验、流式细胞术、试剂盒检测、qPCR和蛋白质印迹法对小鼠进行评估和分析。LcS+京尼平苷提高了脓毒症小鼠的存活率,并增加了总移动距离、小鼠站立次数、小鼠梳理毛发的时间、在目标象限的持续时间和穿越区域数量。对小鼠神经细胞的检测表明,LcS+京尼平苷降低了脓毒症引起的神经细胞凋亡率。LcS+京尼平苷还降低了脓毒症小鼠海马中肿瘤坏死因子-α、白细胞介素-6和白细胞介素-1β等炎症相关指标的量,以及丙二醛(MDA)的氧化相关水平,并提高了超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的氧化酶活性。此外,LcS+京尼平苷增加了脓毒症小鼠海马中SOD1、SOD2和CAT mRNA的表达,并降低了肿瘤坏死因子-α、白细胞介素-1β、核因子-κB和p53 mRNA的表达。LcS+京尼平苷还增加了脓毒症小鼠海马中SIRT1蛋白的表达,并降低了乙酰化叉头框蛋白O1(Ac-FOXO1)、乙酰化核因子-κB(Ac-NF-κB)和乙酰化p53蛋白的表达。我们还观察到LcS+京尼平苷减轻了脓毒症小鼠的炎症和氧化损伤。LcS+京尼平苷的作用与药物地塞米松相似,且比单独使用京尼平苷的效果更强。LcS还增强了京尼平苷激活SIRT1以及降低脓毒症小鼠炎症和氧化应激的能力,并且达到了与使用药物地塞米松相同效果。